Back to top
more

Akorn, Inc. (AKRX)

(Delayed Data from NSDQ)

$3.54 USD

3.54
1,817,551

-0.16 (-4.20%)

Updated Dec 13, 2019 03:56 PM ET

Add to portfolio

2-Buy   2      

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
24.63%
17.80%
9.42%
5.10%
2.04%
10.70%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

C Value | A Growth | A Momentum | B VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Akorn (AKRX) Moves to Strong Buy: Rationale Behind the Upgrade

Akorn (AKRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

AKRX

Indrajit Bandyopadhyay

Generic Drugmakers Gain as Price-Fixing Probe Nears an End

Shares of generic drugmakers rose on Monday on a possible end to the persistent price-fixing probe.

TEVA AKRX ZYNE BHC

Indrajit Bandyopadhyay

Generic Drugs Industry Turns the Corner on Price Stabilization

Stabilizing prices of generic drugs are leading to recovery in the industry. New launches are also a boost. However, competition remains stiff.

ZYNE BHC AKRX

Zacks Equity Research

The Zacks Analyst Blog Highlights: Forterra, Barrett Business, Chuy's, Akorn and Quanex

The Zacks Analyst Blog Highlights: Forterra, Barrett Business, Chuy's, Akorn and Quanex.

NX FRTA AKRX CHUY BBSI

Nalak Das

5 Small-Cap Stocks Outpacing the Broader Market in 2019

Despite the slow pace of movement of small-cap stock prices, a few stocks within this stable have skyrocketed ahead of the large-cap-centric indexes this year.

NX FRTA AKRX CHUY BBSI

Nitish Marwah

New Strong Buy Stocks for November 7th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

OMI LAD CBZ AKRX ACIA

Zacks Equity Research

Akorn (AKRX) Q3 Earnings and Revenues Top Estimates

Akorn (AKRX) delivered earnings and revenue surprises of 150.00% and 0.67%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

AKRX

Zacks Equity Research

Will Akorn (AKRX) Report Negative Earnings Next Week? What You Should Know

Akorn (AKRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AKRX

Zacks Equity Research

All You Need to Know About Akorn (AKRX) Rating Upgrade to Buy

Akorn (AKRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AKRX

Zacks Equity Research

Akorn (AKRX) Reports Q2 Loss, Tops Revenue Estimates

Akorn (AKRX) delivered earnings and revenue surprises of 66.67% and 3.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

AKRX

Zacks Equity Research

Analysts Estimate Akorn (AKRX) to Report a Decline in Earnings: What to Look Out for

Akorn (AKRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AKRX

Zacks Equity Research

Akorn (AKRX) Reports Q1 Loss, Tops Revenue Estimates

Akorn (AKRX) delivered earnings and revenue surprises of 28.57% and 8.44%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

AKRX

Zacks Equity Research

Options Traders Expect Huge Moves in Akorn (AKRX) Stock

Investors need to pay close attention to Akorn (AKRX) stock based on the movements in the options market lately.

AKRX

Zacks Equity Research

Options Traders Expect Huge Moves in Akorn (AKRX) Stock

Investors need to pay close attention to Akorn (AKRX) stock based on the movements in the options market lately.

AKRX

Zacks Equity Research

Akorn (AKRX) Gets FDA Warning Letter for Illinois Facility

Akorn, Inc. (AKRX) suffers a setback with the FDA handing over a warning letter post an inspection of its Illinois manufacturing facility in April and May of 2018.

RDY MYL MNK AKRX

Zacks Equity Research

Do Options Traders Know Something About Akorn (AKRX) Stock We Don't?

Investors need to pay close attention to Akorn (AKRX) stock based on the movements in the options market lately.

AKRX

Zacks Equity Research

Is Akorn (AKRX) Stock a Suitable Pick for Value Investors?

Let's see if Akorn, Inc. (AKRX) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

AKRX

Zacks Equity Research

Implied Volatility Surging for Akorn (AKRX) Stock Options

Investors need to pay close attention to Akorn (AKRX) stock based on the movements in the options market lately.

AKRX

Zacks Equity Research

Is Akorn (AKRX) a Suitable Stock for Value Investors Now?

Let's see if Akorn, Inc. (AKRX) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

AKRX

Zacks Equity Research

AKRX vs. AMPH: Which Stock Should Value Investors Buy Now?

AKRX vs. AMPH: Which Stock Is the Better Value Option?

AKRX AMPH

Zacks Equity Research

Bausch (BHC) Looks Good: Stock Adds 13.9% in Session

Bausch (BHC) shares rose nearly 14% in the last trading session, amid huge volumes.

AKRX BHC

Zacks Equity Research

Akorn Enters Oversold Territory

Akorn has been on a bit of a cold streak lately.

AKRX

Zacks Equity Research

AKRX vs. AMPH: Which Stock Should Value Investors Buy Now?

AKRX vs. AMPH: Which Stock Is the Better Value Option?

AKRX AMPH

Zacks Equity Research

Do Options Traders Know Something About Akorn (AKRX) Stock We Don't?

Investors in Akorn (AKRX) need to pay close attention to the stock based on moves in the options market lately.

AKRX

Zacks Equity Research

Akorn (AKRX) Looks Good: Stock Adds 7.8% in Session

Akorn (AKRX) was a big mover last session, as the company saw its shares rise more than 7% on the day, amid huge volumes.

AKRX AQXP